[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-355021-en":59,"doc-seo-355021-105":99},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":72,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":80,"preview_page_count":19,"preview_urls":81},355021,137441390410,"Hazel","https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Acceptance and the willingness to pay for human papilloma virus (HPV) vaccine - A systematic review","Human papillomavirus (HPV) is a major global health concern due to its link to cervical and other cancers. Although HPV vaccination is highly effective, acceptance and willingness to pay (WTP) differ widely across populations. This review summarizes global evidence from 2015–2025. Systematic searches of PubMed, Scopus, CENTRAL, Web of Science, and Google Scholar were conducted in 2025 using PRISMA. Quality was assessed with ISPOR checklists and data synthesized in Excel 2019. Thirty-five studies met criteria; China and Nigeria contributed most.","REVIEW  \nAcceptance and the willingness to pay for human papilloma virus (HPV) vaccine: A systematic review  \nSoheila Rajaiea,b, Sara Emamgholipoura, Samad Azaric, Zeinab Karimid, and Fereshte Karimib  \naDepartment of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; bResearch Center for Emergency and Disaster Resilience, Red Crescent Society of the Islamic Republic of Iran, Tehran, Iran; cHealth Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran; dTuberculosis and Lung Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran  \nABSTRACT  \nHuman papillomavirus (HPV) is a major global health concern due to its link to cervical and other cancers. Although HPV vaccination is highly effective, acceptance and willingness to pay (WTP) differ widely across populations. This review summarizes global evidence from 2015–2025. A systematic search of PubMed, Scopus, CENTRAL, Web of Science, and Google Scholar was conducted in 2025 following PRISMA guidelines. Studies reporting data on knowledge, acceptance, attitudes, and WTP across any population were included. Quality assessment used ISPOR checklists, and data were synthesized in Excel 2019. Thirty-five studies met inclusion criteria, with China and Nigeria contributing most. WTP ranged from 52.68% in lower-middle-income countries to 65.38% in low-income countries. Mean WTP was highest in upper-middle-income settings. Knowledge, positive attitudes, socioeconomic status, and trust increased WTP, while cost remained the primary barrier. Improving affordability, awareness, and policy support is essential to enhance global HPV.  \nARTICLE HISTORY  \nReceived 1 October 2025 Revised 3 December 2025 Accepted 20 December 2025  \nKEYWORDS  \nHuman papillomavirus; vaccines; vaccine acceptance; willingness to pay; systematic review  \nIntroduction  \nHuman papillomavirus (HPV) is a diverse group of over 200 related viruses, classified into several genera, of which the Alpha genus includes the types responsible for most clinically significant infections. High-risk HPV types, particularly HPV-16 and HPV-18, are etiologically linked to approximately 70% of cervical cancer cases worldwide, as well as a substantial proportion of other anogenital and oropharyngeal cancers. These viruses are primarily transmitted through sexual contact and often cause persistent infections that may progress to malignancy if left untreated. 1,2  \nGlobally, HPV-associated diseases impose an enormous economic burden on health systems and societies. Recent estimates from high-income countries report that the annual direct medical costs of managing HPV-related diseases exceed $9 billion in the United States alone. The major cost components include screening, diagnosis, treatment of precancerous lesions, and cancer care.3 In middle- and lowincome countries, this burden is exacerbated by limited access to effective screening and treatment modalities, resulting in higher mortality and larger population-level impacts,4 For example, in Asia and parts of Africa, cervical cancer remains a leading cause of cancer-related death among women, a trend primarily attributable to HPV infection. This underscores the urgent need for cost-effective prevention strategies.3,5,6  \nVaccination against HPV has emerged as a highly effective and safe intervention to prevent infection and its associated cancers. However, despite the availability of prophylactic vaccines since the mid-2000s, global vaccination coverage remains suboptimal, especially in low-resource settings where coverage rates can fall below 20%, compared to rates exceeding 80% in some high-income countries.7,8  \nHPV vaccination guidelines vary across countries and regions. The World Health Organization (WHO) recommends a 2-dose HPV vaccination schedule (6–12 months apart) for girls aged 9–14 y. For individuals  \nCONTACT Fereshte Karimi ","cbCaigP1vRucdYRz","https://ap.wps.com/l/cbCaigP1vRucdYRz","pdf",1418851,17,"English","en",105,"# Introduction\n## HPV burden and transmission\n## HPV vaccination effectiveness and coverage gaps\n## Vaccination guidelines and schedules\n## Vaccine acceptance and WTP framework","[{\"question\":\"What is the primary focus of this systematic review?\",\"answer\":\"The review focuses on acceptance and willingness to pay (WTP) for the human papillomavirus (HPV) vaccine across different populations.\"},{\"question\":\"Which databases and guidelines were used to find included studies?\",\"answer\":\"Studies were identified through searches of PubMed, Scopus, CENTRAL, Web of Science, and Google Scholar in 2025, following PRISMA guidelines.\"},{\"question\":\"What factors are associated with higher WTP for HPV vaccination?\",\"answer\":\"Higher WTP is associated with knowledge, positive attitudes, socioeconomic status, and trust, while cost is reported as the primary barrier.\"}]","Acceptance and the willingness to pay for human papilloma virus (HPV) vaccine - A systematic review | PDF",1790115440,43,[82,86,90,95],{"page_no":8,"url":83,"width":84,"height":85},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/886bea3559a4e65cf0dd62bcd08ed959.webp",983,1310,{"page_no":14,"url":87,"width":88,"height":89},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6995cae1b326eee557c0e3a59527a01.webp",982,1309,{"page_no":91,"url":92,"width":93,"height":94},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3eb31fa6cf880a19947901fb82203dc3.webp",981,1308,{"page_no":19,"url":96,"width":97,"height":98},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a82d6bb36b6c404141757fa753ddbce.webp",980,1306,{"code":4,"msg":100,"data":101},"ok",{"site_id":75,"language":74,"slug":102,"title":65,"keywords":103,"description":66,"schema_data":104,"social_meta":157,"head_meta":159,"extra_data":161,"updated_unix":162},"acceptance-and-the-willingness-to-pay-for-human-papilloma-virus-hpv-vaccine-a-systematic-review","",{"@graph":105,"@context":156},[106,119,139],{"@type":107,"itemListElement":108},"BreadcrumbList",[109,113,115,117],{"item":110,"name":111,"@type":112,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":114,"name":9,"@type":112,"position":14},"https://docshare.wps.com/document/",{"item":116,"name":40,"@type":112,"position":91},"https://docshare.wps.com/document/research-report/",{"item":118,"name":65,"@type":112,"position":19},"https://docshare.wps.com/document/acceptance-and-the-willingness-to-pay-for-human-papilloma-virus-hpv-vaccine-a-systematic-review/355021/",{"url":118,"name":65,"@type":120,"image":121,"author":126,"headline":65,"publisher":128,"fileFormat":131,"inLanguage":74,"description":66,"dateModified":132,"datePublished":133,"encodingFormat":131,"isAccessibleForFree":134,"interactionStatistic":135},"DigitalDocument",{"url":122,"@type":123,"width":124,"height":125},"https://docshare.wps.com/thumbnails/acceptance-and-the-willingness-to-pay-for-human-papilloma-virus-hpv-vaccine-a-systematic-review/355021.png","ImageObject",300,407,{"name":63,"@type":127},"Person",{"url":110,"name":129,"@type":130},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":136,"interactionType":137,"userInteractionCount":52},"InteractionCounter",{"@type":138},"ViewAction",{"@type":140,"mainEntity":141},"FAQPage",[142,148,152],{"name":143,"@type":144,"acceptedAnswer":145},"What is the primary focus of this systematic review?","Question",{"text":146,"@type":147},"The review focuses on acceptance and willingness to pay (WTP) for the human papillomavirus (HPV) vaccine across different populations.","Answer",{"name":149,"@type":144,"acceptedAnswer":150},"Which databases and guidelines were used to find included studies?",{"text":151,"@type":147},"Studies were identified through searches of PubMed, Scopus, CENTRAL, Web of Science, and Google Scholar in 2025, following PRISMA guidelines.",{"name":153,"@type":144,"acceptedAnswer":154},"What factors are associated with higher WTP for HPV vaccination?",{"text":155,"@type":147},"Higher WTP is associated with knowledge, positive attitudes, socioeconomic status, and trust, while cost is reported as the primary barrier.","https://schema.org",{"og:url":118,"og:type":158,"og:title":65,"og:site_name":129,"og:description":66},"article",{"robots":160,"canonical":118},"index,follow",{"doc_id":61,"site_id":75},1790536003]